Biology Reference
In-Depth Information
[184] McKenna HJ, Stocking KL, Miller RE, Brasel K, De Smedt T, Maraskovsky E, et al. Mice
lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor
cells, dendritic cells, and natural killer cells. Blood 2000;95(11):3489-97.
[185] Tussiwand R, Onai N, Mazzucchelli L, Manz MG. Inhibition of natural type I IFN-
producing and dendritic cell development by a small molecule receptor tyrosine kinase
inhibitor with Flt3 affinity. J Immunol 2005;175(6):3674-80.
[186] Burnham K, Robb L, Scott CL, O'Keeffe M, Shortman K. Effect of granulocyte-macro-
phage colony-stimulating factor on the generation of epidermal Langerhans cells. J
Interferon Cytokine Res 2000;20(12):1071-6.
[187] Koyama M, Kuns RD, Olver SD, Raffelt NC, Wilson YA, Don AL, et al. Recipient nonhe-
matopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-
host disease. Nat Med 2012;18(1):135-42.
[188] Kingston D, Schmid MA, Onai N, Obata-Onai A, Baumjohann D, Manz MG. The
concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis.
Blood 2009;114(4):835-43.
[189] Brasel K, De Smedt T, Smith JL, Maliszewski CR. Generation of murine dendritic cells
from flt3-ligand-supplemented bone marrow cultures. Blood 2000;96(9):3029-39.
[190] Hennies CM, Reboulet RA, Garcia Z, Nierkens S, Wolkers MC, Janssen EM. Selective
expansion of merocytic dendritic cells and CD8DCs confers anti-tumour effect of Fms-
like tyrosine kinase 3-ligand treatment in vivo. Clin Exp Immunol 2011;163(3):381-91.
[191] Barreda DR, Hanington PC, Belosevic M. Regulation of myeloid development and
function by colony stimulating factors. Dev Comp Immunol 2004;28(5):509-54.
[192] Martinez-Moczygemba M, Huston DP. Biology of common beta receptor-signaling
cytokines: IL-3, IL-5, and GM-CSF. J Allergy Clin Immunol 2003;112(4):653-65.
[193] Dekker A, Bulley S, Beyene J, Dupuis LL, Doyle JJ, Sung L. Meta-analysis of randomized
controlled trials of prophylactic granulocyte colony-stimulating factor and granulo-
cyte-macrophage colony-stimulating factor after autologous and allogeneic stem cell
transplantation. J Clin Oncol 2006;24(33):5207-15.
[194] Sung L, Nathan PC, Alibhai SM, Tomlinson GA, Beyene J. Meta-analysis: effect of
prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of
infection. Ann Intern Med 2007;147(6):400-11.
[195] MacDonald KP, Rowe V, Bofinger HM, Thomas R, Sasmono T, Hume DA, et al. The
colony-stimulating factor 1 receptor is expressed on dendritic cells during differentia-
tion and regulates their expansion. J Immunol 2005;175(3):1399-405.
[196] Sherr CJ, Rettenmier CW. The fms gene and the CSF-1 receptor. Cancer Surv
1986;5(2):221-32.
[197] Hume DA, MacDonald KP. Therapeutic applications of macrophage colony-stimu-
lating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood
2012;119(8):1810-20.
[198] Cecchini MG, Dominguez MG, Mocci S, Wetterwald A, Felix R, Fleisch H, et al. Role of
colony stimulating factor-1 in the establishment and regulation of tissue macrophages
during postnatal development of the mouse. Development 1994;120(6):1357-72.
[199] Hashimoto D, Chow A, Greter M, Saenger Y, Kwan WH, Leboeuf M, et al. Pretransplant
CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic
hematopoietic cell transplantation. J Exp Med 2011;208(5):1069-82.
[200] Praloran V, Raventos-Suarez C, Bartocci A, Lucas J, Stanley E, Gibbons J. Alterations in
the expression of colony-stimulating factor-1 and its receptor during an acute graft-vs-
host reaction in mice. J Immunol 1990;145(10):3256-61.
[201] Blazar BR, Aukerman SL, Vallera DA. Effect of recombinant human macrophage colony-
stimulating factor in irradiated murine recipients of T-cell-depleted allogeneic or non-
depleted syngeneic bone marrow transplants. Blood 1992;79(6):1636-42.
[202] MacDonald KP, Palmer JS, Cronau S, Seppanen E, Olver S, Raffelt NC, et al. An antibody
against the colony-stimulating factor 1 receptor depletes the resident subset of mono-
cytes and tissue- and tumor-associated macrophages but does not inhibit inflamma-
tion. Blood 2010;116(19):3955-63.
[203] Masaoka T, Shibata H, Ohno R, Katoh S, Harada M, Motoyoshi K, et al. Double-blind
test of human urinary macrophage colony-stimulating factor for allogeneic and synge-
neic bone marrow transplantation: effectiveness of treatment and 2-year follow-up for
relapse of leukaemia. Br J Haematol 1990;76(4):501-5.
[204] Nemunaitis J, Meyers J, Buckner C, Shannon-Dorcy K, Mori M, Shulman H, et al. Phase
I trial of recombinant human macrophage colony-stimulating factor in patients with
invasive fungal infections. Blood 1991;78(4):907-13.
[205] Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood
1991;78(11):2791-808.
390
Search WWH ::
Custom Search